QBKPN SSI
AssetAlso QBKPN
Inactivated K. pneumoniae components restore innate immune homeostasis in the lungs and respiratory tract.
- Stage
- Phase 2
- Modality
- Other
- Target
- Not known
- 4
- Indications
- 0
- Trials
- 1
- Developer
Indications
4Decline in innate immune function in the elderly
Phase 2, qubiologics.com, 10 Oct 2026
Recurrent lung cancer
Phase 2, qubiologics.com, 10 Oct 2026
Asthma
Preclinical, qubiologics.com, 10 Oct 2026
1 more
In the full profile
- Owner and partners1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.